About this trial
GnRH-a will be used to postpone period after vaginal repair for Cesarean Section Scar Defect(CSD) patients with adenomyosis which will be compared with CSD patients with adenomyosis who receive transvaginal surgery without GnRH-a, whether delayed period improving the CSD prognosis will be assessed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clearly diagnosed with CSD complicated with adenomyosis
Experiencing clinical features of abnormal uterine bleeding, prolonged menstrual flow (the duration of menstruation is more than 10 days).
The thickness of the remaining muscular layer of CSD was less than 3 mm.
Normal range of blood sugar and insulin
Disqualifiers
Indefinite diagnosis.
Malignant tumors.
With severe medical problems (severe liver disease, kidney disease, respiratory diseases, heart disease or uncontrolled diabetes, epilepsy, etc., dysfunction of important organs).
Pregnant.
Trial design
Parallel
Treatments tested in this trial
Leuprorelin
DrugLeuprorelin will be used to postpone period after vaginal repair.
Treatment groups
Trial outcomes
Primary outcomes
thickness of the remaining muscular layer (TRM) (mm)
The thickness of the remaining muscular layer is measured by magnetic resonance imaging (MRI)
Duration of menstruation (day)
Duration of menstruation (day)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.